Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer (Q39576387)
Jump to navigation
Jump to search
scientific article published on 30 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer |
scientific article published on 30 July 2012 |
Statements
1 reference
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer (English)
1 reference
Armando Santoro
1 reference
Luis G Paz-Ares
1 reference
Bonne Biesma
1 reference
David Heigener
1 reference
Joachim von Pawel
1 reference
Timothy Eisen
1 reference
Jaafar Bennouna
1 reference
Li Zhang
1 reference
Meilin Liao
1 reference
Yan Sun
1 reference
Steven Gans
1 reference
Kostas Syrigos
1 reference
Etienne Le Marie
1 reference
Maya Gottfried
1 reference
Johan Vansteenkiste
1 reference
Vincente Alberola
1 reference
Uwe Phillip Strauss
1 reference
Elaine Montegriffo
1 reference
Teng Jin Ong
1 reference
NSCLC [non–small-cell lung cancer] Research Experience Utilizing Sorafenib (NExUS) Investigators Study Group
1 reference
30 July 2012
1 reference
1 reference
3084-3092
1 reference
Identifiers
1 reference